To elucidate the potential role of the ras protooncogene proteins in a specific tissue, the present study determined the levels of individual c-ras-encoded p21 proteins in the rat ovary during various stages of physiological function. p21 protein was extracted from ovaries taken from immature normal female rats, mature nonpregnant animals in the metestrus stage of the estrus cycle, rats at various stages of pregnancy, and actively lactating animals. Levels of individual p2ls were evaluated by immunoblot analysis with specific antibodies to the p21 proteins encoded by the Kirsten, Harvey, and neuroblastoma c-ras protooncogenes, c-Ki-ras, c-Ha-ras, and N-ras. Results showed that c-Ki-ras p21 is at its lowest level in the immature ovary and increases with development of the corpora lutea to its highest levels at day 16 of pregnancy, after which levels decline and then rise again during lactation. This pattern, which mimics that of circulating progesterone levels, suggests that ovarian c-Ki-ras p21 levels are regulated and that c-Ki-ras p21 plays a role in the differentiated function of the rat ovary, likely the luteal compartment. In contrast, levels of c-N-ras p21 did not appear to vary with changes in the physiological function of the ovary but appeared to be constitutive. A preferential role for the c-Ki-ras p21 may be due to the documented unique differences in the structure of the carboxyl terminus of this particular c-ras p21.
Results of recent studies show the importance of a variety of cellular oncogene products not only in the control of proliferation but also in differentiated function of normal eukaryotic cells (1) . Of particular interest is the cellular ras (c-ras) gene family, a group of very highly conserved genes present in yeasts to primates (2, 3) . The c-ras genes encode markedly similar 21-kDa proteins (p21) that are localized to the inner face of the plasma membrane, bind guanine nucleotides, and have significant structural homology to other GTP-binding proteins (G proteins), including the adenylate cyclaseassociated G proteins (2, 3) . Unlike their role in yeasts, however, in mammalian cells c-ras G proteins do not function as part of the cyclase pathway (4) . Although various data demonstrate that mammalian c-ras p21 proteins influence the efficacy of membrane receptor signal-transduction pathways (5, 6) , the specific function of the c-ras p21s in any mammalian cell type has not been defined. In efforts to more clearly define their specific role, examination of total c-ras p21 expression in various normal human and rat tissues has been performed (7) (8) (9) . Yet these studies have been limited to evaluation of total p21 content rather than determination of the individual p21 proteins and have not defined whether changes in differentiated function of a tissue are associated with variations in p21 protein levels. Since changes in differentiated function of specific compartments in the mammalian ovary are well documented by the reflected patterns in circulating levels of steroid hormones, the ovary is an excellent model for study of developmental changes. However, studies of ovarian p21 expression have been extremely limited with regards to species and physiological status.
The present studies were performed to examine expression of the specific c-ras p21 proteins in the normal rat ovary and to determine if expression of the individual p21 proteins varies with changes in the differentiated function of the ovarian corpus luteum. We examined expression of the Kirsten, Harvey, and neuroblastoma c-ras protooncogenes, c-Kiras, c-Ha-ras, and N-ras.t While other studies have investigated individual c-ras mRNA levels, important posttranscriptional and posttranslational modifications of the individual c-ras proteins suggest that evaluation at the protein level is likely to reveal significant facts regarding c-ras function. We demonstrate specific quantitative modifications in the expression of rat ovarian c-Ki-ras p21 protein, which appear to mimic the pattern of progesterone secretion, whereas in contrast, levels of N-ras p21 appear to be constitutive.
MATERIALS AND METHODS
Reagents. Anti-c-Ki-ras, anti-N-ras, and anti-c-Ha-ras mouse monoclonal antibodies, purified from ascites fluid by nondenaturing liquid chromatography, were obtained from Oncogene Science (Uniondale, NY). The immunogens used to generate these antibodies were bacterially derived recombinant fusion proteins constituting residues 66-189 of the respective human c-ras p2ls and a portion of the trpE gene product. All pure ras proteins used were recombinant human c-ras p2ls also obtained from Oncogene Science. The specificity ofthe c-Ki-ras antibody has been reported (10) , and the specificities of the N-ras and c-Ha-ras antibodies were confirmed before use. Data shown in lanes 1-3 of Fig. 2 Quantitation of p21 Proteins. The densitometric values obtained for the signals generated by the enhanced chemiluminescent method were quantitated by using double logarithmic plots of signal versus amount of loaded protein. The accuracy of quantitation by these methods has been demonstrated (13) . Standardization for the presently described experiments was done with various amounts of pure p2ls. Double logarithmic plots of the densitometric values versus the amounts of pure p2ls loaded showed linear relationships for the different exposure times that were employed in the present studies. This was also true for tissue extracts electrophoresed and blotted in an identical manner. We observed, using various amounts of the ovarian extracts, a similar log-log relationship with different exposure times. The slopes of the extract curves were in close agreement with those of the standard curves. Slopes of both the standard and the extract curves were determined by linear regression using the StatView SE + Graphics statistical analysis package (Abacus Concepts, Berkeley, CA) and a Macintosh SE/30 computer. Thus, using the standard curves generated by loading known amounts of pure p21 protein in each experiment, we were able to obtain nanogram values, relative to the p21 standards, for the p2is detected in the tissue extracts.
This method was reproducible: for the c-K-ras p2l, the interassay coefficient of variation at 10, 20, and 30 ng was 5.2%, 6.0%, and 9.6%, respectively (n = 5 at each quantity); for the N-ras p21, the interassay coefficient of variation at 20 and 30 ng was 8.1% and 9.5%, respectively (n = 4 at each quantity).
RESULTS
To understand the role of c-ras p2ls in differentiated function of the rat ovary, we first established the presence of these proteins in this endocrine organ and compared them with levels in other normal rat tissues. For evaluation of the c-K-ras p21, we used the exon 4B-specific antibody, since this exon is thought to be predominantly utilized in normal mammalian cells (14, 15) . c-Ki-ras p21 levels were highly variable from tissue to tissue (Fig. 1) . The brain and lung appeared to have fairly high amounts of the c-Ki-ras p21, while the levels in the ovary and spleen were lower but quite substantial. Skeletal muscle appeared to lack c-Ki-ras p21, although a related lower molecular weight protein (-15 kDa) seemed to be quite abundant. A similarly sized c-ras-related protein has been shown to be present in human skeletal muscle as well (8) . Levels of the c-Ki-ras p21 in the pancreas were barely detectable.
Generally, the levels of N-ras p21 appeared to be consistently higher than those of c-Ki-ras p21 in all tissues examined ( Fig. 2) with the exception of skeletal muscle, in which N-ras p21, like c-Ki-ras p21, was not detectable. Levels of N-ras p21 were highest in brain and lung but were more uniformly distributed in the other tissues studied than were levels of c-Ki-ras p21. Also, in contrast to the levels of c-Ki-ras p21, which were barely detectable, a substantial amount of N-ras p21 was present in the pancreas. Data regarding levels of c-Ki-ras and N-ras p21 in various tissues were consistently observed with repeated performance of the study, regardless of the detection system used. These data are consistent with previous observations of the abundance of total c-ras p2is in the mammalian brain (7) (8) (9) .
Blots that were probed with the c-Ha-ras p21 antibody failed to show detectable signals with any of the tissue extracts except with the extract from brain, which showed a faint band in the 21-kDa region (data not presented). In contrast, the pure c-Ha-ras p21 as well as c-Ha-ras p21 expressed in a mouse NIH 3T3 cell line were detected by this antibody. Similar lack of detection of c-Ha-ras p21 in normal rat tissues was observed by Tanaka et al. (7) . These results were somewhat surprising, since previous preliminary results detected c-Ha-ras mRNA specific transcripts in the rat ovary (16) . Results of studies by Cohen et al. (17) support the concept that the majority of message transcripts generated from the c-Ha-ras gene enter a splicing pathway that is nonproductive, while only a small fraction form the mRNA that is translated to the 21-kDa protein. Thus, although the c-Ha-ras protooncogene may be transcribed efficiently, at least in the ovary, it is possible that the transcripts are not translated to a 21-kDa protein, explaining our lack of detection of very low quantities of c-Ha-ras p21. Since our previous preliminary data suggested that the levels of the higher molecular weight c-Ki-ras mRNA transcript vary with different stages of development of the rat ovary (16), and since George et al. (15) have demonstrated that this message transcript can be actively translated, we determined whether this change is reflected at the protein level. Fig. 3 shows a c-Ki-ras p21 Western blot analysis of extracts from immature (lane 6), day 16 pregnant (lane 7), and day 1 postdelivery (lane 8) rat ovaries. It is clear from this figure that when the rat ovary is in a highly differentiated state (day 16 of pregnancy), the relative amount of c-Ki-ras p21 (based on total protein) is much higher than when it is at a stage of lesser differentiated function (immature and day 1 postdelivery). To verify and amplify these findings, we performed a more detailed study of c-Ki-ras p21 levels during rat ovarian differentiation. p21 protein was extracted from ovaries taken from immature animals, mature nonpregnant animals in metestrus, animals at various stages of pregnancy, and actively lactating animals after which c-Ki-ras p21 levels were identified by Western blot analysis. The results clearly showed (Figs. 4 and 5 ) that c-Ki-ras p21 is at its lowest level in the immature ovary and increases with differentiation, reaching a maximum at day 16 of pregnancy, the time at which corpora lutea are most actively functioning. With subsequent degeneration of the corpora lutea (day 21 of pregnancy and day 1 postdelivery), the levels of c-Ki-ras p21 decline, only to rise again, very dramatically, when corpora lutea resume an active function (day 8 of lactation).
Similar analyses of these extracts for N-ras p21 content was performed (Figs. 6 and 7) . These data show that the levels of N-ras p21 do not change with development of the ovary but rather appear to be constitutive, a finding that reflects our earlier preliminary results, which suggested that N-ras mRNA transcript levels do not change with ovarian development (16) . In contrast to the clearly detectable levels I, immature 24-day-old rats; M, rats in the metestrus phase; d9-d21, day 9, day 12, day 16, and day 21 pregnant rats; dlpp, rats at day 1 postpartum; and d8L, lactating rats at day 8 after delivery. Experimental conditions are the same as described in the legend for of both N-and c-K-ras p21 levels in the ovary, c-Ha-ras p21 was not detectable at any stage of rat ovarian development.
DISCUSSION
The morphological and endocrinological changes that occur in the rat ovary during the estrus cycle, throughout pregnancy, and in the lactational period have been well documented (18) . In this species, ovarian secretion of progesterone rises at the metestrus phase of the estrus cycle, reflecting formation of corpora lutea after ovulation. When pregnancy ensues, developing corpora lutea secrete increasing quantities of progesterone, which peak at about day 16 of pregnancy, after which progesterone secretory activity declines, reflecting luteal demise, which occurs toward the end of the -22-day gestational period. In the absence of lactation, progesterone levels remain very low in the postpartum period. With lactation, progesterone secretion from newly developed corpora lutea increases, so that by day 8 of lactation, circulating progesterone concentrations are similar to the highest levels seen during pregnancy. The present examination of the expression of the individual ras p2ls demonstrates that levels of c-Ki-ras p21, unlike levels of N-ras p21, vary with ovarian development. The pattern of levels of ovarian c-Ki-ras p21 bears a marked similarity to the well-established pattern of progesterone secretion. These results suggest that the c-Ki-ras p21 specifically has a role to play in the differentiated function of the rat ovary, likely in the luteal compartment. Although the nature of this role is unknown at present, since various studies have implicated p2ls in signal transduction in other mammalian cell types (5, 6) , it is possible that the c-Ki-ras p21 subserves this role in ovarian cells as well, supplementing other signal transduction mechanisms at physiological times when enhanced response to tropic factors is needed to allow increased hormone output. Thus, the increases in basal ovarian c-Ki-ras p21 levels during pregnancy may be a significant mechanism by which increased progesterone or other hormone secretion can occur. It is also unknown whether c-Ki-ras p21 is involved in ovarian cell division. However, that the labeling index of luteal cells (the predominant ovarian cell type during pregnancy) is extremely low at the times during pregnancy when c-Ki-ras p21 levels are increasing (19) suggests that this is not the case. Elevated levels of total c-ras p21s have been demonstrated in brain and heart nondividing tissues (7-9) as well as in certain terminally differentiated cells, including endocrine cells and neurons (8, 9) , supporting the concept that p21 function may be unrelated to cell proliferation in certain cell types. Differences in the levels of the RNA transcripts corresponding to the different c-ras genes, especially for the N-ras gene, have been observed in various adult tissues and during prenatal and postnatal development in the mouse, suggesting tissue-specific function for each of the c-ras gene products and that tissue-specific regulation of the N-ras gene may occur in response to different physiological needs (20) . The preferential changes in ovarian c-Ki-ras p21 levels demonstrated in the present study suggest that ovarian c-Ki-ras p21 is regulated, whereas N-ras and Ha-ras p21 levels are constitutively produced. The factors responsible for regulating the production of ovarian c-Ki-ras p21 are presently unknown and cannot even be hypothesized, but certainly warrant further study. Although regulation of c-Kiras and c-Ha-ras and c-myc, but not c-abl and c-src, transcription during regenerative growth of the rat liver has been reported (21), the present study shows evidence for regulation of p21 levels during a physiological functional developmental period.
Our results suggest that, unlike c-Ki-ras p21, neither N-ras nor Ha-ras p21 levels are regulated during differentiation of the rat ovary. Such differential regulation of expression has been reported for the three members of the c-myc family of protooncogenes in the developing mouse kidney (22) . Although there is no direct evidence to explain the preferential regulation of c-Ki-ras p21 levels, it is reasonable to postulate that differences in the carboxyl termini of the c-ras p2ls may be responsible for differences in their in vivo physiological functions. The mature c-Ki-ras (4B) p21 has been shown to be quite different at its carboxyl terminus from the c-Ha-ras and N-ras p21s (23) . During posttranslational processing, while c-Ha-ras and N-ras p2is are palmitoylated (on cysteines 181 and 184) as well as polyisoprenylated (at the carboxyl-terminal cysteine-186), c-Ki-ras (4B) p21 is only polyisoprenylated but not palmitoylated because the c-Ki-ras p21 lacks cysteine upstream of 186. Moreover, the carboxyl terminus of c-Ki-ras (4B) p21 contains a run of six positively charged lysine residues that, it has been postulated, may be responsible for increased avidity of membrane binding, which may be required because lack of palmitoylation would decrease the extent and avidity of membrane binding (23) . These data further suggest that c-Ki-ras p21 may be directed to a different membrane compartment than palmitoylated c-ras proteins (23) . These properties might be responsible for conferring a specialized physiological function upon the c-Ki-ras p21. In addition, it is now becoming evident that farnesyl is the isoprenoid moiety added to the carboxyl terminus of c-ras proteins (24) . This finding provides a link between sterol biosynthesis and processing of c-ras p2ls (25) , since farnesyl is a cholesterol precursor. The fact that the differentiated ovary is actively steroidogenic suggests that an abundance of steroid precursors might favor accumulation of large amounts of properly processed c-ras p2ls, supporting their potential role in signal transduction during this stage. Selectively increasing the levels of c-Ki-ras p21 may be advantageous for the ovary, as the increased availability of palmitic acid is not an additional prerequisite for posttranslational processing of this particular c-ras p21.
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